Nations Can’t ‘Just Pretend The Pandemic Is Over,’ WHO Director Says
In the U.S., while new cases decline nationally, areas of the Midwest continue to surge. And hospitalizations and deaths among kids are rising.
The independent source for health policy research, polling, and news.
18,741 - 18,760 of 112,719 Results
In the U.S., while new cases decline nationally, areas of the Midwest continue to surge. And hospitalizations and deaths among kids are rising.
Today's early morning highlights from the major news organizations.
Editorial pages focus on these public health issues and others.
Global news reports are from Indonesia, China, England, Iran, Chile, Mexico, Tanzania, Zambia, Japan and Germany.
But Arizona, a former hot spot for positive cases, is emerging from lockdown as an example of how aggressive restrictions can flatten the curve.
The cancer that killed 43-year-old Chadwick Boseman is the second leading cause of cancer deaths in the United States. Other medical news includes addiction treatment, dermatology and darker skins, pediatrics, and ALS and medical marijuana.
Teachers unions across the country are filing lawsuits in court to avoid going back to work in person with their students. And colleges report more and more cases of coronavirus among their students back on campus.
The 25-year-old man from Nevada was much sicker the second time. Three other reinfections are known to exist, calling into question the immune systems' ability to prevent more serious illness.
Many are skipping annual physicals altogether or relying on telemedicine, including pet owners.
It's almost flu season and the anti-vaccine advocates are fighting with officials in numerous states over flu shots for children.
The food giant is buying a California biopharmaceutical company in a deal that values the startup at $2.6 billion.
On Friday, the inventor showed off a prototype of the device developed by his startup, Neuralink.
As the prospects of a coronavirus vaccine improve, the logistics of getting Americans vaccinated appear daunting and not just because only half of Americans say they are highly likely to get the shot.
The FDA announced the antiviral can be used in any patient. "It seems to be a pattern of approval without science, without data, without evidence," said Dr. Eric Topol, vice president at Scripps Research.
Negotiations in Congress for a fifth COVID relief bill is now tied to negotiations to avoid another government shutdown. And neither are going well.
The powerful hurricane that hit Gulf Coast states damaged refineries, petrochemical plants and plastics factories, which could have released dangerous pollutants into the air. But some key state and federal monitors to alert the public remain offline in Louisiana.
With no social distancing and few masks in use, 1,500 Trump campaign supporters crowded together to hear Donald Trump's convention speech Thursday night. Public health experts worry that guests could have been infected. Meanwhile, the political conventions did not much change impressions of Trump or Joe Biden.
And the reputations of both public health agencies could be further impacted by impressions that they are bowing to political pressure from the White House.
In interviews with the Financial Times and Bloomberg, FDA Commissioner Stephen Hahn spoke about the conditions under which he would consider granting emergency authorization for a COVID-19 vaccine. The comments come a week after President Donald Trump accused the FDA of dragging its feet on vaccine approval to hurt him politically.
In addition to removing Trump-appointee Emily Miller from her post after only 11 days on the job, the FDA also terminated the contract of a public relations consultant. The moves are seen as an effort to restore the credibility of the agency.
© 2026 KFF